The Venture Codex Logo

The Venture Codex

Eos Bioinnovation

One Broadway, 14th Floor, Cambridge, MA, 02142, United States

Overview

Investment firm focused on launching regenerative medicine start-ups.

Founded

2022

Deals ยท 12mo

2

Links

Website

Stage focus

Seed
Series A

Geographic focus

Canada
Switzerland
United States

Sector focus

Health Care
Venture Capital

Investment portfolio

5rounds
NAMEDATESIZE
Autoimmunity BioSolutions
May 2026Led
$1 MSeed
TECregen
Jan 2026Participated
$13 MSeed
Autoimmunity BioSolutions
Nov 2024Led
$2 MSeed
Axonis Therapeutics
Oct 2024Participated
$115 MSeries A
HDAX Therapeutics
Sep 2024Participated
$3 MSeed
Autoimmunity BioSolutions
May 2026Led
$1 MSeed
TECregen
Jan 2026Participated
$13 MSeed
Autoimmunity BioSolutions
Nov 2024Led
$2 MSeed
Axonis Therapeutics
Oct 2024Participated
$115 MSeries A
HDAX Therapeutics
Sep 2024Participated
$3 MSeed
5
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Eos Bioinnovation: 5 funding rounds are recorded in the selected participation categories.All available history.
Eos Bioinnovation: 5 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed22
Series A01

Monthly Deal Activity

Eos Bioinnovation: 5 deals are recorded across 26 months.All available history.
Eos Bioinnovation: 5 deals are recorded across 26 months. All available history
MonthDeals
Sep '241
Oct '241
Nov '241
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Eos Bioinnovation: Health & Life Sciences is the largest displayed sector by deal count (5 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Eos Bioinnovation: Health & Life Sciences is the largest displayed sector by deal count (5 deals). All available history
SectorDeals
Health & Life Sciences5
Manufacturing1
Consumer & Lifestyle1

Deal Size Distribution

Eos Bioinnovation: 5 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Eos Bioinnovation: 5 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M3
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Eos Bioinnovation: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Eos Bioinnovation: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
Europe1
Canada1
Eos Bioinnovation: 20 co-investors are shown, with Alexandria Venture Investments sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Eos Bioinnovation: 20 co-investors are shown, with Alexandria Venture Investments sharing 2 recorded deals. All available history
Co-investorShared deals
Alexandria Venture Investments2
Independent Capital2
Boehringer Ingelheim1
BoxOne Ventures1
Carma Fund1
Cormorant Asset Management1
Elmstead Partners1
FACIT1
Hatteras Venture Partners1
High-Tech Grunderfonds1
Iaso Ventures1
JFG Life Sciences Foundation1
LifeSpan Vision Ventures1
Lumira Ventures1
MRL Ventures Fund1
NewTech Investment Holdings1
Ontario Centre of Innovation1
Pathway BioVentures1
Perceptive Advisors1
SCI Ventures1

Investment Strategy

Eos Bioinnovation: Led accounts for 40% and participating for 60% of round participation.All available history.
Eos Bioinnovation: Led accounts for 40% and participating for 60% of round participation. All available history
CategoryDeals (count)Share (%)
Led240%
Participating360%
Eos Bioinnovation: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Eos Bioinnovation: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead2100%
Co-led00%

Team

Brock Reeve

Co-Founder

Jimmy Lu

Managing Director